Data_Sheet_1_Dynamic TF-lncRNA Regulatory Networks Revealed Prognostic Signatures in the Development of Ovarian Cancer.PDF
The pathological development of ovarian cancer (OC) is a complex progression that depends on multiple alterations of coding and non-coding genes. Therefore, it is important to capture the transcriptional-regulating events during the progression of OC development and to identify reliable markers for predicting clinical outcomes in patients. A dataset of 399 ovarian serous cystadenocarcinoma patients at different stages from The Cancer Genome Atlas (TCGA) was analyzed. Stage-specific transcription factor (TF)-long non-coding RNA (lncRNA) regulatory networks were constructed by integrating high-throughput RNA molecular profiles and TF binding information. Systematic analysis was performed to characterize the TF-lncRNA-regulating behaviors across different stages of OC. Cox regression analysis and Kaplan-Meier survival curves were used to evaluate the prognostic efficiency of TF-lncRNA regulations and cliques. The stage-specific TF-lncRNA regulatory networks at three OC stages (II, III, and IV) exhibited common structures and specific topologies of risk TFs and lncRNAs. A TF-lncRNA activity profile across different stages revealed that TFs were highly stage-selective in regulating lncRNAs. Functional analysis indicated that groups of TF-lncRNA interactions were involved in specific pathological processes in the development of OC. In a STAT3-FOS co-regulating clique, the TFs STAT3 and FOS were selectively regulating target lncRNAs across different OC stages. Further survival analysis indicated that this TF-lncRNA biclique may have the potential for predicting OC prognosis. This study revealed the topological and dynamic principles of TF-lncRNA regulatory networks and provided a resource for further analysis of stage-specific regulating mechanisms of OC.
History
References
- https://doi.org//10.1371/journal.pone.0080306
- https://doi.org//10.1038/nrc2946
- https://doi.org//10.1038/nature10166
- https://doi.org//10.1038/nature08712
- https://doi.org//10.1002/cam4.710
- https://doi.org//10.1186/1471-2105-14-128
- https://doi.org//10.4161/cbt.10.5.12585
- https://doi.org//10.1038/nm1093
- https://doi.org//10.1038/nsmb.2591
- https://doi.org//10.3892/ol.2016.5400
- https://doi.org//10.1097/IGC.0000000000001097
- https://doi.org//10.1186/1476-4598-10-38
- https://doi.org//10.1016/j.cell.2011.02.013
- https://doi.org//10.1101/gr.135350.111
- https://doi.org//10.1371/journal.pone.0001334
- https://doi.org//10.1093/bioinformatics/btn429
- https://doi.org//10.1093/nar/gkg129
- https://doi.org//10.1093/nar/gkw377
- https://doi.org//10.1177/1535370213508216
- https://doi.org//10.1016/j.canlet.2016.09.019
- https://doi.org//10.1038/srep15953
- https://doi.org//10.1016/j.knosys.2019.105261
- https://doi.org//10.1158/1078-0432.CCR-11-0735
- https://doi.org//10.1007/s12013-007-0040-7
- https://doi.org//10.1016/j.cell.2012.04.040
- https://doi.org//10.1038/nm.2492
- https://doi.org//10.18632/oncotarget.10004
- https://doi.org//10.1371/journal.pone.0103851
- https://doi.org//10.1038/513S10a
- https://doi.org//10.1016/j.ccell.2015.09.008
- https://doi.org//10.1186/s13059-016-0956-6
- https://doi.org//10.1038/nbt.1518
- https://doi.org//10.1016/S0140-6736(11)60126-8
- https://doi.org//10.3322/caac.21442
- https://doi.org//10.1158/1078-0432.CCR-12-1257
- https://doi.org//10.2147/OTT.S214689
- https://doi.org//10.1016/j.ygyno.2012.06.022
- https://doi.org//10.1093/nar/gkv233
- https://doi.org//10.3892/mmr.2014.3094
- https://doi.org//10.1038/nature05911
- https://doi.org//10.1158/1078-0432.CCR-10-2315
- https://doi.org//10.1093/bioinformatics/bti042
- https://doi.org//10.1038/s41419-018-0908-z
- https://doi.org//10.1158/1541-7786.MCR-11-0177
- https://doi.org//10.1007/s13277-015-4770-7
- https://doi.org//10.1038/nature14982
- https://doi.org//10.1186/1471-2105-15-110
- https://doi.org//10.1109/TNB.2019.2922214
Usage metrics
Read the peer-reviewed publication
Categories
- Bioprocessing, Bioproduction and Bioproducts
- Industrial Biotechnology Diagnostics (incl. Biosensors)
- Industrial Microbiology (incl. Biofeedstocks)
- Industrial Molecular Engineering of Nucleic Acids and Proteins
- Industrial Biotechnology not elsewhere classified
- Medical Biotechnology Diagnostics (incl. Biosensors)
- Biological Engineering
- Regenerative Medicine (incl. Stem Cells and Tissue Engineering)
- Medical Biotechnology not elsewhere classified
- Agricultural Marine Biotechnology
- Biomaterials
- Biomechanical Engineering
- Biotechnology
- Biomarkers
- Biomedical Engineering not elsewhere classified
- Genetic Engineering
- Synthetic Biology
- Bioremediation
- Medical Molecular Engineering of Nucleic Acids and Proteins